HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety and efficacy of zoledronic acid in multiple myeloma.

AuthorsAthanassios Kyrgidis, Thrasivoulos-George Tzellos
JournalLancet (London, England) (Lancet) Vol. 377 Issue 9784 Pg. 2177-8 (Jun 25 2011) ISSN: 1474-547X [Electronic] England
PMID21704864 (Publication Type: Comparative Study, Letter, Randomized Controlled Trial, Comment)
Chemical References
  • Diphosphonates
  • Imidazoles
  • Clodronic Acid
  • Zoledronic Acid
Topics
  • Clodronic Acid (administration & dosage, adverse effects)
  • Diphosphonates (administration & dosage, adverse effects)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Interactions
  • Female
  • Humans
  • Imidazoles (administration & dosage, adverse effects)
  • Incidence
  • Male
  • Multiple Myeloma (diagnosis, drug therapy, mortality)
  • Osteonecrosis (chemically induced, epidemiology)
  • Prognosis
  • Risk Assessment
  • Safety Management
  • Severity of Illness Index
  • Survival Analysis
  • Thromboembolism (chemically induced, epidemiology)
  • Zoledronic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: